Cramer’s lightning round: Incyte Corporation is a good one

Incyte Corporation: “That one makes no sense that it’s down here. I think you got a really good one. I think you should maybe buy even more than you have. I don’t get it. This company actually makes money. It’s real good. I think the big boys are going to come to it. Nice call.” Nautilus Biotechnology: “That’s an Andreessen Horowitz-[backed] company. Look, this is one is too small for me to just point-blank say, ‘You’re absolutely right. We’ve got to love it.’ I’ve got to do more work on…

Read More

Amazon invested millions in a pre-revenue company with a system for measuring human proteins

Andy Jassy, CEO of Amazon and then CEO of Amazon Web Services, listens during the Amazon Web Services Summit in San Francisco on April 19, 2017. David Paul Morris | Bloomberg | Getty Images Amazon invested millions in a pre-revenue biotechnology company that went public after merging with a special-purpose acquisition company in early June, according to a regulatory filing released last week. The move fits with Amazon’s efforts to build a presence in health care. The online retailer now operates an online pharmacy following the $753 million acquisition of…

Read More